Table 5 Demographic and clinical data of patients without (C-) or with (C+) post-stroke cognitive decline. F, female; M, male
From: Increased serum QUIN/KYNA is a reliable biomarker of post-stroke cognitive decline
|  | C- patients (n = 10) | C+ patients (n = 13) | P |
|---|---|---|---|
Gender (F/M) | 4/6 | 5/8 | 1 |
Mean age ± SD (years) | 64.7 ± 13.3 | 69.4 ± 17.8 | 0.38 |
Diabetes | 1 | 2 | 1 |
Hypertension | 5 | 8 | 0.685 |
Fibrinolysis | 8 | 12 | 0.5596 |
Thrombectomy | 5 | 6 | 1 |
Anterior circulation | 7 | 13 | 0.4561 |
Posterior circulation | 3 | 0 | 0.0678 |
Cardio-embolic | 4 | 6 | 1 |
Atheroma | 4 | 5 | 1 |
Undetermined | 2 | 2 | 1 |